On the way in the door as the new CEO of Hologic, Stephen MacMillan said he would oversee further growth of the women's diagnostic medical imaging and surgical products company, despite Hologic's recent efforts to reorganize.
For Carl Icahn and his allies, acquiring 12.6% of Hologic shares gave them enough leverage to start getting their way. As part of an agreement with Icahn, the company added two new independent directors and replaced its CEO.
Johnson & Johnson's DePuy Synthes arm plans to spend more than $36 million to build up a research-and-development operation in Ireland.
Boston Scientific's soon-to-be-departing chief financial officer has sold off nearly 600,000 shares in November on his way out the door, bringing nearly $7 million, and a number of other senior executives also unloaded hundreds of thousands of shares. Some observers see the move as a predictor of more measured longer-term prospects for the rebounding company.
Irish medical device giant Covidien over the weekend announced a definitive agreement to acquire PillCam maker Given Imaging for $860 million, ending about a year of takeover talk.
MIT scientist and entrepreneur Robert Langer is co-founding yet another new med tech company, this time in France. Gecko Biomedical debuts with nearly $11 million in Series A financing, focused on a light-activated, biodegradable, non-toxic adhesive designed to close wounds inside the body.
The FDA backs a market that lets consumers easily gain information about their genomes and genetic risks, an agency official said, despite its move to stop 23andMe from selling its direct-to-consumer health-related genetic tests until they obtain formal regulatory approval.
Boston Children's Hospital spinout Claritas Genomics, a genetic diagnostic testing company, attracted an investment from IT specialist Cerner, and the two will collaborate to develop a computing infrastructure designed to smooth the diagnostic process from start to finish.
Switzerland's Biocartis will link up with Belgium's VIB research institute to develop a diagnostic test useful for colorectal and other cancers, the company said.
Medtronic is touting stellar 7-year postmarketing patient results for one of its key artificial disc implants designed to treat degenerative spinal conditions. Researchers presented the data at a major conference--a shot of good news for the Minnesota company's struggling spinal division.
Notching another CE mark in its cardiac cache, Italian devicemaker Sorin nabbed European approval for its Intensia family of implantable cardiac defibrillator and cardiac resynchronization therapy devices.
California's 23andMe has capitulated to the FDA, agreeing to regulators' demands to stop selling all health-related genetic tests while it submits them for a formal regulatory review.
When Thermo Fisher Scientific announced a $3.2 billion bond offering Wednesday, Fitch Ratings promptly lowered the medical device maker's credit rating to BBB and Moody's Investors Service said it likely will do the same.
Jarvik Heart won Japanese regulatory approval for its left ventricular assist device, bringing its heart pump rivalry with Thoratec to Asia. Japan's Pharmaceuticals and Medicines Devices Agency signed off on the Jarvik 2000 Heart based on Japanese and U.S. clinical trial data, approving it as a bridge to transplant.
Albany, NY, device outfit AngioDynamics is planning to consolidate two of its plants, shedding up to 100 employees in an effort to save as much as $18 million over the next three years.
Harris Martin reported that a U.S. district judge threw out a patient's lawsuit alleging that U.K. orthopedics giant Smith & Nephew's metal hip replacement left her in pain, disabled and needing replacement surgery.
Medtronic announced Thursday it has approval in the EU and Australia to market its new system for renal denervation to treat uncontrolled hypertension.
Cardiac stents lose out in two new studies that conclude bypass surgery and drugs are better or equal options in helping to prevent future heart attacks from happening, at least for patients with stable heart disease.
This didn't take long. Myriad Genetics' attorneys have struck again and filed a suit this time against LabCorp, barely two days after LabCorp launched a series of predictive cancer diagnostic tests focused on BRCA mutations.
Bloomberg reported that Intuitive Surgical has issued a recall affecting more than 1,300 robot arms of its da Vinci surgical around the world because they may be producing too much friction. When that happens, the da Vinci can choke during surgery and briefly stop working before it catches up.